HMGA2 and neoplasm: The results of this study demonstrated the capability of CDX-LIPO in promoting autophagy, tumor cell death, and tumor regression via promoting anti-tumor immunity through the activation of a variety of immune cells, including natural killer cells (NKCs), dendritic cells, and primed T-cells.